Anti-PD1 antibody: a new approach to treatment of lymphomas

被引：32
|
作者：
Bachy, Emmanuel [1 ,2 ,3 ]
Coiffier, Bertrand [1 ,2 ,3 ]
机构：
[1] Hosp Civils Lyon, Dept Hematol, Lyon, France
[2] Univ Lyon 1, Dept Hematol, F-69365 Lyon, France
[3] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 01期
关键词：
FOLLICULAR LYMPHOMA; T-CELLS; PD-1;
D O I：
10.1016/S1470-2045(13)70587-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [41] Toxic epidermal necrolysis due to anti-PD1 treatment with fatal outcome
    Demirtas, S.
    El Aridi, L.
    Acquitter, M.
    Fleuret, C.
    Plantin, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2017, 144 (01): : 65 - 66
  • [42] Anti-PD-1 antibody treatment for melanoma
    Ribas, Antoni
    Kirkwood, John M.
    Flaherty, Keith T.
    LANCET ONCOLOGY, 2018, 19 (05): : E219 - E219
  • [43] Anti-PD1 treatment of advanced melanoma: development of criteria for a safe stop
    Lorigan, P.
    Eggermont, A. M. M.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1038 - 1040
  • [44] Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer
    Kaufman, Bar
    Abramov, Orli
    Ievko, Anna
    Apple, Daria
    Shlapobersky, Mark
    Allon, Irit
    Greenshpan, Yariv
    Bhattachrya, Baisali
    Cohen, Ofir
    Charkovsky, Tatiana
    Gayster, Alexandra
    Shaco-Levy, Ruthy
    Rouvinov, Keren
    Livoff, Alejandro
    Elkabets, Moshe
    Porgador, Angel
    SCIENCE ADVANCES, 2023, 9 (21)
  • [45] Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
    Wang, Chao
    Ye, Yanqi
    Hochu, Gabrielle M.
    Sadeghifar, Hasan
    Gu, Zhen
    NANO LETTERS, 2016, 16 (04) : 2334 - 2340
  • [46] Telomerase-specific oncolytic adenovirus amplifies immunogenic effects with anti-PD1 antibody
    Hashimoto, Masashi
    Kuroda, Shinji
    Kanaya, Nobuhiko
    Yagi, Chiaki
    Tsumura, Tomoko
    Kumon, Kento
    Kakiuchi, Yoshihiko
    Kikuchi, Satoru
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2021, 112 : 399 - 399
  • [47] Systemic analysis of innate responses to anti-PD1/PD-L1 treatment in a melanoma model
    Gassen, Rodrigo
    Welm, Alana
    Bonorino, Cristina
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody
    Wang, Chao
    Sun, Wujin
    Wright, Grace
    Wang, Andrew Z.
    Gu, Zhen
    ADVANCED MATERIALS, 2016, 28 (40) : 8912 - 8920
  • [49] Antitumor activity of lenvatinib in combination with everolimus or an anti-PD1 antibody in preclinical RCC models
    Adachi, Yusuke
    Kimura, Takayuki
    Matsuki, Masahiro
    Matsui, Junji
    Funahashi, Yasuhiro
    CANCER RESEARCH, 2018, 78 (13)
  • [50] A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use
    Aasems Jacob
    Dileep C. Unnikrishnan
    Aju Mathew
    Braghadheeswar Thyagarajan
    Shil Patel
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1869 - 1870
12345